IL226239B - Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same - Google Patents
Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for sameInfo
- Publication number
- IL226239B IL226239B IL226239A IL22623913A IL226239B IL 226239 B IL226239 B IL 226239B IL 226239 A IL226239 A IL 226239A IL 22623913 A IL22623913 A IL 22623913A IL 226239 B IL226239 B IL 226239B
- Authority
- IL
- Israel
- Prior art keywords
- dopa
- inhibitors
- catechol
- compositions
- same
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL226239A IL226239B (en) | 2010-11-15 | 2013-05-08 | Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41363710P | 2010-11-15 | 2010-11-15 | |
US201161524064P | 2011-08-16 | 2011-08-16 | |
PCT/IL2011/000881 WO2012066538A1 (en) | 2010-11-15 | 2011-11-15 | Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
IL226239A IL226239B (en) | 2010-11-15 | 2013-05-08 | Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
Publications (2)
Publication Number | Publication Date |
---|---|
IL226239A0 IL226239A0 (en) | 2013-07-31 |
IL226239B true IL226239B (en) | 2019-01-31 |
Family
ID=48917273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL226239A IL226239B (en) | 2010-11-15 | 2013-05-08 | Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL226239B (en) |
-
2013
- 2013-05-08 IL IL226239A patent/IL226239B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL226239A0 (en) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL263954A (en) | Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same | |
ZA201109037B (en) | Compositions for continuous administration of dopa decarboxylase inhibitors | |
HK1246674A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
ZA201206223B (en) | Certain kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions, and methods of use thereof | |
HK1199726A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3- | |
HK1162352A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3- | |
HK1198619A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3- | |
EP2534145A4 (en) | Therapeutic methods and compositions involving allosteric kinase inhibition | |
IL223865B (en) | Calcium salts of dihydroorotate dehydrogenase inhibitors, compositions comprising the same and uses thereof | |
IL226239B (en) | Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |